[

oxford

]

Gout drug to be tested as potential Covid-19 treatment by second UK study

After a UK study dubbed Recovery, another study in Britain to test gout medication colchicine as potential Covid-19 treatment
Gout drug to be tested as potential Covid-19 treatment by second UK study(Photo by Daniel Schludi on Unsplash)
Gout drug to be tested as potential Covid-19 treatment by second UK study(Photo by Daniel Schludi on Unsplash)
Updated on Mar 03, 2021 08:11 PM IST
Copy Link
Reuters |

Oxford names ‘Aatmanirbharta’ as Hindi word of the year for 2020

The Oxford Hindi word of the year is a word or expression that is chosen to reflect the ethos, mood, or preoccupations of the passing year, and have lasting potential as a term of cultural significance.
When Prime Minister Narendra Modi announced India’s Covid-19 recovery package, he emphasised the need to become self-reliant as a country.(ANI)
When Prime Minister Narendra Modi announced India’s Covid-19 recovery package, he emphasised the need to become self-reliant as a country.(ANI)
Published on Feb 03, 2021 04:12 AM IST
Copy Link
PTI | , New Delhi

UK begins Oxford-AstraZeneca vaccination as spike prompts new curbs

For the sixth consecutive day, the UK recorded over 50,000 new cases, prompting new calls for another lockdown by Labour, and health authorities reconsidering the current four-tier alert system that is increasingly assessed as being unable to control the numbers.
James Shaw receives the Oxford University/AstraZeneca Covid-19 vaccine from advanced nurse practitioner Justine Williams, at the Lochee Health Centre in Dundee, Scotland, Britain on January 4.(Reuters)
James Shaw receives the Oxford University/AstraZeneca Covid-19 vaccine from advanced nurse practitioner Justine Williams, at the Lochee Health Centre in Dundee, Scotland, Britain on January 4.(Reuters)
Updated on Jan 04, 2021 07:58 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar , edited by Vinod Janardhanan

Oxford, Bharat Biotech vaccines cleared for use

The Subject Expert Committee consists of domain experts from the fields of pulmonology, immunology, microbiology, pharmacology, paediatrics, internal medicine and so on .
Doses of the Covid-19 vaccine developed by Oxford University and UK-based drugmaker AstraZeneca are checked as they arrive at the Princess Royal Hospital in Haywards Heath, England.(AP File photo)
Doses of the Covid-19 vaccine developed by Oxford University and UK-based drugmaker AstraZeneca are checked as they arrive at the Princess Royal Hospital in Haywards Heath, England.(AP File photo)
Updated on Jan 04, 2021 01:31 AM IST
Copy Link
Hindustan Times, New Delhi | ByRhythma Kaul

Oxford, AstraZeneca will supply 2mn vaccine doses a week in UK: Report

Health Secretary Matt Hancock said earlier this week that only 530,000 doses of the vaccine would be ready on Monday. The Oxford team is frustrated that the poor state of the country’s manufacturing capacity has affected the pace of production, the Times of London said, citing the group member.
The UK has ordered 100 million doses of the Oxford vaccine, according to the newspaper.(Reuters file photo)
The UK has ordered 100 million doses of the Oxford vaccine, according to the newspaper.(Reuters file photo)
Updated on Jan 02, 2021 08:17 AM IST
Copy Link
ByBloomberg| Posted by: Harshit Sabarwal

India likely to start the new year with a Covid vaccine, hints DCGI

The Subject Expert Committee will meet on January 1 to consider the emergency-use authorisation application of Pfizer, Serum Institute of India, and Bharat Biotech’s Covaxin
Representational image.(REUTERS)
Representational image.(REUTERS)
Updated on Dec 31, 2020 02:42 PM IST
Copy Link
Hindustan Times, New Delhi | ByAnonna Dutt

Serum Institute request for emergency use of Oxford vaccine to be considered today

The move comes after UK’s Medicines and Healthcare products Regulatory Agency (MHRA) granted emergency-use approval to the vaccine on Wednesday
Representational photo.(AFP)
Representational photo.(AFP)
Updated on Dec 30, 2020 02:43 PM IST
Copy Link
Hindustan Times, New Delhi | ByRhythma Kaul

Oxford says Covid-19 vaccine has good immune response with 2-dose regime

The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs to be done to affirm the result.
The details from the Phase I/II clinical trials released on Thursday made no reference to the half-dose/full-dose regime, which Oxford has said had been “unplanned” but approved by regulators.(Reuters image)
The details from the Phase I/II clinical trials released on Thursday made no reference to the half-dose/full-dose regime, which Oxford has said had been “unplanned” but approved by regulators.(Reuters image)
Updated on Dec 18, 2020 06:17 AM IST
Copy Link
Washington | ByReuters | Posted by Prashasti Singh

Fashion Focus: The Marvellous Ms Clapton

From Game of Thrones to The Crown, award-winning British costume designer Michele Clapton has threaded, be-glitzed and outfitted some of the most iconic characters on screen
British costume designer Michele Clapton’s sartorial influences over the last 20 years have run so deep that they’ll be remembered as pop-cultural tropes for decades to come
British costume designer Michele Clapton’s sartorial influences over the last 20 years have run so deep that they’ll be remembered as pop-cultural tropes for decades to come
Updated on Dec 13, 2020 08:31 AM IST
Copy Link
Hindustan Times | ByDrishti Vij

Spectator by Seema Goswami: Take a shot

Now that the Covid vaccine is here, it’s time to plan for a post-pandemic reality
The Covid-19 vaccine is ready and about to hit the market all across the world(Aparna Ram)
The Covid-19 vaccine is ready and about to hit the market all across the world(Aparna Ram)
Published on Dec 13, 2020 07:56 AM IST
Copy Link
Hindustan Times | BySeema Goswami

Study: AstraZeneca Covid-19 vaccine safe and effective

The results on a positive Covid-19 vaccine from Oxford University , Astreneca suggests that it is safe and about 70% effective.
The results on a positive Covid-19 vaccine from Oxford University , Astreneca suggests that it is safe and about 70% effective.(Unsplash)
The results on a positive Covid-19 vaccine from Oxford University , Astreneca suggests that it is safe and about 70% effective.(Unsplash)
Updated on Dec 09, 2020 10:26 AM IST
Copy Link
ByAssociated Press | Postrd by Shivani Kale

India to look at full-dose data of Oxford vaccine

The Oxford-AstraZeneca vaccine has shown an efficacy of 62% when volunteers were given two full doses of the vaccine, but a higher 90% when the first was a half-strength dose, according to interim results from trials in the United Kingdom and Brazil.
Experts have previously said that the Oxford-AstraZeneca vaccine’s lower efficacy should not be seen as worrying.(AP file photo)
Experts have previously said that the Oxford-AstraZeneca vaccine’s lower efficacy should not be seen as worrying.(AP file photo)
Updated on Dec 08, 2020 05:02 AM IST
Copy Link
Hindustan Times, New Delhi | ByAnonna Dutt

Serum Institute seeks approval for Covid-19 vaccine; Adar Poonawalla thanks PM for support

The institute’s move comes on the heels of the US pharmaceutical giant, Pfizer, applying for a similar approval with the DCGI
Vials of COVISHIELD before they are packaged inside a lab at Serum Institute of India, Pune, earlier in November.(File photo)
Vials of COVISHIELD before they are packaged inside a lab at Serum Institute of India, Pune, earlier in November.(File photo)
Updated on Dec 07, 2020 06:49 PM IST
Copy Link
Hindustan Times, New Delhi | ByHT Correspondent | Edited by Smriti Sinha

SII to seek emergency licence in two weeks

The announcement comes at the end of a week when Oxford and AstraZeneca announced their vaccine had shown to be at least 62% (and up to 90%) effective in an interim analysis based on 131 infections in the clinical trials being held in the United Kingdom and Brazil.
The Oxford-AstraZeneca vaccine is also being tested among Indian volunteers as part of global phase 3 trials in different populations.(REUTERS)
The Oxford-AstraZeneca vaccine is also being tested among Indian volunteers as part of global phase 3 trials in different populations.(REUTERS)
Updated on Nov 29, 2020 05:30 AM IST
Copy Link
Hindustan Times, New Delhi | ByRhythma Kaul and Saubhadra Chatterji

Oxford Covid-19 vaccine: Serum Institute to apply for emergency authorisation in 2 weeks

University of Oxford and AstraZeneca on Monday said that their Covid-19 vaccine was up to 90 per cent effective in late-stage clinical trials.
Image for representation.(AFP)
Image for representation.(AFP)
Updated on Nov 28, 2020 08:43 PM IST
Copy Link
Hindustan Times, Pune | ByYogesh Joshi | Edited by Sparshita Saxena

AstraZeneca faces more vaccine questions after manufacturing error

While an announcement Monday by Astra and Oxford showed their shot was 70% effective on average in a late-stage study, the scant details released by the UK partners have sparked worries about whether regulators would clear it.
Astra and Oxford said their vaccine was 90% effective when a half-dose was given before a full-dose booster, and that two full doses showed an efficacy of 62%.(REUTERS)
Astra and Oxford said their vaccine was 90% effective when a half-dose was given before a full-dose booster, and that two full doses showed an efficacy of 62%.(REUTERS)
Updated on Nov 26, 2020 06:08 PM IST
Copy Link
ByBloomberg | Posted by Srivatsan K C

Biocon chief hopes for DCGI nod for Oxford-AstraZeneca Covid-19 vaccine in emergency cases

Referring to “100 Million Doses By January” remark by Serum Institute of India CEO Adar Poonawalla, Kiran Mazumdar-Shaw tweeted that she hopes that the Drugs Controller General of India (DCGI) will give its nod as soon as it gets approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
FILE PHOTO: AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration(REUTERS)
FILE PHOTO: AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration(REUTERS)
Updated on Nov 24, 2020 02:18 PM IST
Copy Link
New Delhi | ByPress Trust of India | Posted by Karan Manral

Dosing error turns into lucky punch for AstraZeneca and Oxford

The British drugmaker said on Monday that the vaccine could be around 90% effective, when administered as a half dose followed by a full dose a month later, citing data from late-stage trials in Britain and Brazil.
A larger group who had received two full doses - as planned - resulted in an efficacy read-out of 62%, leading to an overall efficacy of 70% across both dosing patterns.(Reuters)
A larger group who had received two full doses - as planned - resulted in an efficacy read-out of 62%, leading to an overall efficacy of 70% across both dosing patterns.(Reuters)
Updated on Nov 24, 2020 02:37 AM IST
Copy Link
ByReuters | Posted by Shivani Kumar

Covid-19: Boost for India as Oxford vaccine candidate shot up to 90% successful

The makers of the vaccine will now approach regulators with the full data from the trial to seek an emergency use licence, which will allow for it to be given to people who need it at the earliest: health care workers at the frontlines of the pandemic and people vulnerable to serious illness.
Known as AZD1222, the vaccine has long been the best hope for India — it is cheaper to make, easier to store and distribute, faster to scale up than its two rivals that have shown promise till now.(Reuters)
Known as AZD1222, the vaccine has long been the best hope for India — it is cheaper to make, easier to store and distribute, faster to scale up than its two rivals that have shown promise till now.(Reuters)
Updated on Nov 24, 2020 01:20 AM IST
Copy Link
Hindustan Times, New Delhi | ByPrasun Sonwalkar and Rhythma Kaul, New Delhi

‘Highly effective’ Oxford vaccine raises hopes of normal life from April

The analysis of its data from the trial in the UK and Brazil said the AZD1222 vaccine is highly effective in preventing Covid-19, with no hospitalisations or severe cases reported in participants receiving the vaccine.
In this file photo taken on September 11, a laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.(AFP file)
In this file photo taken on September 11, a laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.(AFP file)
Updated on Nov 23, 2020 06:55 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar , edited by Vinod Janardhanan

How does Oxford Covid-19 vaccine, with 70% efficacy, stack against Pfizer, Moderna?

While 70 per cent efficacy of AZD1222 would have been considered a huge breakthrough a month back, it may be seen by some as relatively disappointing when compared to 95 per cent efficacy of vaccines developed by Pfizer and Moderna.
The phase 3 interim analysis of Oxford/AstraZeneca Covid-19 vaccine candidate showed 70.4 per cent efficacy.(REUTERS)
The phase 3 interim analysis of Oxford/AstraZeneca Covid-19 vaccine candidate showed 70.4 per cent efficacy.(REUTERS)
Updated on Nov 23, 2020 04:17 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Kunal Gaurav

AstraZeneca Covid-19 vaccine can be 90% effective, results show

The British drugmaker’s preliminary trial results mark a fresh breakthrough in the fight against the coronavirus pandemic that has killed nearly 1.4 million people and roiled the global economy.
AstraZeneca says late-stage trials of its Covid-19 vaccine were
AstraZeneca says late-stage trials of its Covid-19 vaccine were "highly effective'' in preventing disease.(AP Photo)
Published on Nov 23, 2020 02:44 PM IST
Copy Link
London | ByReuters | Posted by Kanishka Sarkar

‘Delighted’, tweets Adar Poonawalla as Oxford vaccine claims 70% efficacy

Covishield, as the Oxford vaccine is known in India, is a low-cost, logistically manageable vaccine against Covid-19, the SII CEO said after the announcement of the initial efficacy results.
Several countries are looking forward to Oxford vaccine as it will be cheaper than Moderna and Pfizer vaccines. (HT Photo)
Several countries are looking forward to Oxford vaccine as it will be cheaper than Moderna and Pfizer vaccines. (HT Photo)
Updated on Nov 23, 2020 02:46 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Poulomi Ghosh

UK secures early access to 355 million doses of prospective Covid-19 vaccines

Health secretary Matt Hancock said on Friday that recent news from the Pfizer and Oxford trials was promising
People walk in the rain past Christmas decorations in central London on November 20.(AFP)
People walk in the rain past Christmas decorations in central London on November 20.(AFP)
Published on Nov 21, 2020 12:26 AM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

The I’m Special calendar: A new-year revolution

Brought out by Swarga Foundation in Coimbatore, it features differently abled people each year and is now drawing hundreds of applicants. Meet the 12 young achievers of 2021.
Tinkesh Kaushik, who lost three of his limbs in a kite-flying accident, is now a fitness trainer and Mr March.(Courtesy Swarga Foundation)
Tinkesh Kaushik, who lost three of his limbs in a kite-flying accident, is now a fitness trainer and Mr March.(Courtesy Swarga Foundation)
Updated on Nov 21, 2020 12:01 PM IST
Copy Link
Hindustan Times | ByNatasha Rego

Oxford scientists expect Covid-19 vaccine data by Christmas

Oxford is developing its vaccine in conjunction with the drugmaker AstraZeneca.
A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration.(Reuters File Photo)
A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration.(Reuters File Photo)
Published on Nov 20, 2020 06:54 AM IST
Copy Link
London | ByAssociated Press | Posted by Kanishka Sarkar

The I’m Special calendar: A new-year revolution

Brought out by Swarga Foundation in Coimbatore, it features differently abled people each year and is now drawing hundreds of applicants. Meet the 12 young achievers of 2021.
Tinkesh Kaushik, who lost three of his limbs in a kite-flying accident, is now a fitness trainer and Mr March.(Courtesy: Swarga Foundation)
Tinkesh Kaushik, who lost three of his limbs in a kite-flying accident, is now a fitness trainer and Mr March.(Courtesy: Swarga Foundation)
Published on Nov 20, 2020 06:30 AM IST
Copy Link
Hindustan Times | ByNatasha Rego

News updates from Hindustan Times: To curb surge in Covid-19 cases in Ahmedabad administration decides to impose night curfew and all the latest news

Here are today’s top news, analysis, and opinion at 9 pm. Know all about the latest news and other news updates from Hindustan Times.
With the number of coronavirus cases witnessing a surge, the Ahmedabad administration has decided to impose night curfew in the city(Hindustan Times)
With the number of coronavirus cases witnessing a surge, the Ahmedabad administration has decided to impose night curfew in the city(Hindustan Times)
Updated on Nov 19, 2020 09:02 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com

Oxford’s Covid-19 vaccine safe in older adults, induces immune response: Lancet

The Phase 2 trial of the Oxford vaccine has been found to be safe in healthy older adults and induces immune response, The Lancet reported on Thursday
An illustration shows vials with Covid-19 vaccine stickers, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on November 17.(AFP)
An illustration shows vials with Covid-19 vaccine stickers, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on November 17.(AFP)
Published on Nov 19, 2020 07:10 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

Storage of Pfizer’s Covid-19 vaccine challenge for most nations; India examining possibilities: Govt

The government further said a national scheme on Covid-19 vaccine distribution is in its final stages of preparation.
A woman walks by Pfizer's New York headquarters as New York City tries to contain a spike in Covid-19 cases on November 16, 2020 in New York City.(AFP)
A woman walks by Pfizer's New York headquarters as New York City tries to contain a spike in Covid-19 cases on November 16, 2020 in New York City.(AFP)
Published on Nov 17, 2020 09:47 PM IST
Copy Link
New Delhi | ByPress Trust of India | Posted by Arpan Rai
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Sunday, December 05, 2021